BD Handed US FDA Warning Letter In Lead-Test Investigation
Executive Summary
The agency letter cites quality systems, Medical Device Reporting and device clearance concerns. It stems from an ongoing investigation into lead tests distributed by Magellan Biosciences that sometimes give faulty results.